
The move will likely ease the worries of thousands of Indians who have been prescribed the drug for certain ailments — including malaria and autoimmune disorders like rheumatoid arthritis and lupus — but are facing difficulty in getting it after India lifted a ban on its export last week.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Xxz2Fd
via
IFTTT
0 comments:
Post a Comment